Cognition Therapeutics Inc SEC filings CGTX

Cognition Therapeutics Inc has 303 filings in SEC EDGAR's recent list, going back to Jan 29, 2009. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, listing notice). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Apr 27, 2026 —
DEF 14A Proxy statement Apr 27, 2026 Jun 17, 2026
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 18, 2025
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 7, 2024
DEFA14A Additional proxy material Apr 24, 2023 —
DEF 14A Proxy statement Apr 24, 2023 Jun 9, 2023
DEFA14A Additional proxy material Apr 25, 2022 —
DEF 14A Proxy statement Apr 25, 2022 Jun 10, 2022

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CGTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Purchase, NY
SEC filer status
, Emerging growth company
SEC CIK
1455365
Former names
COGNITION THERAPUTICS INC (until Dec 28, 2010)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.